Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-034065

Chief Medical Officer gave up 24,045 shares (to pay taxes)

  • Chief Medical Officer acquired 87,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gordon David N. Chief Medical Officer 2020-06-01 Option exercise +87,500 106,940 D
Gordon David N. Chief Medical Officer 2020-06-01 Shares withheld for taxes −24,045 $1.32 $31,739 82,895 D
Derivatives
Gordon David N. Chief Medical Officer 2020-06-01 Option exercise · Restricted stock units −87,500 87,500 D
Loading xslF345X03/doc4.xml…